Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

被引:148
作者
Alexander, J
del Guercio, MF
Maewal, A
Qiao, L
Fikes, J
Chesnut, RW
Paulson, J
Bundle, DR
DeFrees, S
Sette, A
机构
[1] Epimmune Inc, San Diego, CA 92121 USA
[2] Univ Alberta, Dept Chem, Edmonton, AB, Canada
[3] Cytel Corp, San Diego, CA 92121 USA
关键词
D O I
10.4049/jimmunol.164.3.1625
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Linear carbohydrate-peptide constructs based on the 13 amino acid nonnatural pan DR epitope (PADRE) and carbohydrate B cell epitopes are demonstrated to be potent immunogens. These data support our belief that PADRE should be considered as an alternative to more complex carriers for use in prophylaxis and therapeutic vaccines. Two model carbohydrate-PADRE glycoconjugates were used to demonstrate that PADRE could effectively provide T cell help for carbohydrate-specific Ab responses. Conjugates of PADRE covalently linked to the human milk oligosaccharide, lacto-N-fucopentose II or a dodecasaccharide derived from Salmonella typhimurium O-Ag induced high titer IgG Ab responses in mice, which were comparable to glycoconjugates employing human serum albumin (HSA) as the carrier protein. Different adjuvants, in combination with PADRE conjugates, allowed for the modulation of the isotype profile with alum supporting an IgG1 profile; QS-21 an IgG2a, 2b profile, while an alum/QS-21 mixture generated a balanced IgG1/IgG2b isotype profile. As defined by binding to synthetic glycoconjugates, dodecasaccharide-specific Abs exhibited fine specificity similar to protective polyclonal Ab responses previously reported for dodecasaccharide-protein conjugates, The same Abs bound to intact S. typhimurium cells, suggesting that biologically relevant specificities were produced, The affinity of the dodecasaccharide-specific Abs was further shown to be comparable to that of a well-characterized, high affinity monoclonal anti-carbohydrate Ab recognizing the same epitope.
引用
收藏
页码:1625 / 1633
页数:9
相关论文
共 54 条
[1]   MONOCLONAL-ANTIBODIES OF 3 DIFFERENT IMMUNOGLOBULIN-G ISOTYPES PRODUCED BY IMMUNIZATION WITH A SYNTHETIC PEPTIDE OR NATIVE PROTEIN PROTECT MICE AGAINST CHALLENGE WITH PLASMODIUM-YOELII SPOROZOITES [J].
AK, M ;
BOWER, JH ;
HOFFMAN, SL ;
SEDEGAH, M ;
LEES, A ;
CARTER, M ;
BEAUDOIN, RL ;
CHAROENVIT, Y .
INFECTION AND IMMUNITY, 1993, 61 (06) :2493-2497
[2]   The optimization of helper T lymphocyte (HTL) function in vaccine development [J].
Alexander, J ;
Fikes, J ;
Hoffman, S ;
Franke, E ;
Sacci, J ;
Appella, E ;
Chisari, FV ;
Guidotti, LG ;
Chesnut, RW ;
Livingston, B ;
Sette, A .
IMMUNOLOGIC RESEARCH, 1998, 18 (02) :79-92
[3]   DEVELOPMENT OF HIGH POTENCY UNIVERSAL DR-RESTRICTED HELPER EPITOPES BY MODIFICATION OF HIGH-AFFINITY DR-BLOCKING PEPTIDES [J].
ALEXANDER, J ;
SIDNEY, J ;
SOUTHWOOD, S ;
RUPPERT, J ;
OSEROFF, C ;
MAEWAL, A ;
SNOKE, K ;
SERRA, HM ;
KUBO, RT ;
SETTE, A ;
GREY, HM .
IMMUNITY, 1994, 1 (09) :751-761
[4]   SYNTHETIC PEPTIDES AS THE BASIS FOR VACCINE DESIGN [J].
ARNON, R .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :209-215
[5]   OPPOSITE EFFECTS OF ACTIVELY AND PASSIVELY ACQUIRED-IMMUNITY TO THE CARRIER ON RESPONSES OF HUMAN INFANTS TO A HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINE [J].
BARINGTON, T ;
GYHRS, A ;
KRISTENSEN, K ;
HEILMANN, C .
INFECTION AND IMMUNITY, 1994, 62 (01) :9-14
[6]  
BASTEN A, 1973, CONTEMP TOPICS IMMUN, V2, P265
[7]  
Berzofsky J A, 1991, Biotechnol Ther, V2, P123
[8]  
BIXLER GS, 1989, ADV EXP MED BIOL, V251, P175
[9]   PNEUMOCOCCAL VACCINE EFFICACY IN SELECTED POPULATIONS IN THE UNITED-STATES [J].
BOLAN, G ;
BROOME, CV ;
FACKLAM, RR ;
PLIKAYTIS, BD ;
FRASER, DW ;
SCHLECH, WF .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (01) :1-6
[10]   MOUSE IGG3 ANTIBODIES ARE HIGHLY PROTECTIVE AGAINST INFECTION WITH STREPTOCOCCUS-PNEUMONIAE [J].
BRILES, DE ;
CLAFLIN, JL ;
SCHROER, K ;
FORMAN, C .
NATURE, 1981, 294 (5836) :88-90